Early haemorrhagic morbidity and mortality during remission induction with or without all‐trans retinoic acid in acute promyelocytic leukaemia

Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia

1988 • 2,380 citations

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1991 • 1,298 citations

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]

1990 • 1,224 citations

All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

1997 • 1,090 citations

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group

1993 • 521 citations

Molecular Remission in PML/RARα-Positive Acute Promyelocytic Leukemia by Combined All-trans Retinoic Acid and Idarubicin (AIDA) Therapy

1997 • 492 citations

A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients

1991 • 412 citations

All-trans Retinoic Acid for Acute Promyelocytic Leukemia: Results of the New York Study

1994 • 288 citations

TRANEXAMIC ACID FOR CONTROL OF HAEMORRHAGE IN ACUTE PROMYELOCYTIC LEUKAEMIA

1989 • 265 citations

AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study

1996 • 262 citations

All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group [see comments]

1995 • 258 citations

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases

1992 • 240 citations

Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients [see comments]

1990 • 239 citations

Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group.

1998 • 213 citations

Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid

1995 • 135 citations

Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.

1993 • 130 citations

Idarubicin (4‐demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: A pilot study of the Italian cooperative group GIMEMA

1990 • 84 citations

Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.

1994 • 26 citations

2. All-trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia

2007 • 23 citations

Significant reduction of medical costs by differentiation therapy withall-trans retinoic acid during remission induction of newly diagnosed patients with acute promyelocytic leukemia

1995 • 22 citations

[All-trans-retinoic acid in the treatment of acute promyelocytic leukemia].

1990 • 20 citations

Four years' experience with the treatment of all‐trans retinoic acid in acute promyelocytic leukemia

1993 • 17 citations

All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.

1992 • 13 citations

All-trans retinoic acid in acute promyelocytic leukemia: Preliminary results in Cuba

1992 • 7 citations